To find the clinical trial on ClinicalTrials.gov please search NCT01603407. Corticosteroids are the only treatment documented to improve strength and increase muscle mass in boys with Duchenne muscular dystrophy (Duchenne). Despite an American Academy of Neurology practice guideline and Cochrane report recommending their use, corticosteroid use is haphazard in timing, dosage schedule, and duration and in some countries not prescribed to most patients. The FOR-DMD study examines the three most commonly prescribed corticosteroid regimens. This webinar includes a presentation of the aims of the FOR-DMD study, along with discussion of why the study is particularly relevant in regard to current/future DMD clinical trials. A parent of one of the FOR-DMD study subjects was also available for participant questions.
by: Parent Project Muscular Dystrophy
